ZYME Q2 2022 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+207.3% YoY

Gross Profit

-$51M-929.4% margin

Operating Income

-$66M-1209.5% margin

Net Income

-$65M-1187.4% margin

EPS (Diluted)

$-0.97

QoQ Revenue Growth

+184.0%

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$59M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$369M

Total Liabilities

$147M

Stockholders' Equity

$222M

Cash & Equivalents

$199M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$2M	+207.3%
Gross Profit	-$51M	-$49M	-3.4%
Operating Income	-$66M	-$69M	+4.4%
Net Income	-$65M	-$68M	+4.3%

Revenue Segments

License

$5M92%

Other Product

$442,0008%